Results 61 to 70 of about 18,981 (120)

A Minimum 3-Year Follow-Up of Nivolumab-Plus-Ipilimumab in Japanese Patients With Advanced or Metastatic Renal Cell Carcinoma: A Final Analysis of the J-ENCORE Study. [PDF]

open access: yesInt J Urol
Hamamoto S   +14 more
europepmc   +1 more source

IRIS: Interpretable Risk Clustering Intelligence for Survival Analysis. [PDF]

open access: yesProc IEEE Int Conf Big Data
Noshin K   +6 more
europepmc   +1 more source

Online tutorial on survival analysis for biomarker discovery. [PDF]

open access: yesPLoS Comput Biol
Kokošar J   +6 more
europepmc   +1 more source

Retrorectal tumors over 25 years: Surgical strategies and long-term outcomes from a high-volume tertiary center. [PDF]

open access: yesMedicine (Baltimore)
Kutluk F   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy